| 11002 | A | 200771 | 002 | IRINOTECAN HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | IRINOTECAN HYDROCHLORIDE | EMCURE PHARMS LTD | 100MG/5ML (20MG/ML) | | [] | 2012-02-14 | Feb 14, 2012 | No | No | No | DISCN | EMCURE PHARMACEUTICALS LTD | 56a5e1089a41a82fe15038bca3ba13141b3c3298c7cad80be30d9f64eeff9872 |
| 11003 | A | 213278 | 001 | IRINOTECAN HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | IRINOTECAN HYDROCHLORIDE | EUGIA PHARMA | 40MG/2ML (20MG/ML) | AP | ["AP"] | 2020-11-02 | Nov 2, 2020 | No | No | No | RX | EUGIA PHARMA SPECIALITIES LTD | df12359ba5069d8aa3bccdfda009ca5b69d37c0d47cb2b10953df92d592fceef |
| 11004 | A | 213278 | 002 | IRINOTECAN HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | IRINOTECAN HYDROCHLORIDE | EUGIA PHARMA | 100MG/5ML (20MG/ML) | AP | ["AP"] | 2020-11-02 | Nov 2, 2020 | No | No | No | RX | EUGIA PHARMA SPECIALITIES LTD | 9c33fe9c6390ae5bc61c96a04c75aa63e9b85e4881f82701a06aefed9acf222b |
| 11005 | A | 213278 | 003 | IRINOTECAN HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | IRINOTECAN HYDROCHLORIDE | EUGIA PHARMA | 300MG/15ML (20MG/ML) | AP | ["AP"] | 2020-11-02 | Nov 2, 2020 | No | No | No | RX | EUGIA PHARMA SPECIALITIES LTD | 335fbd0f8824af4a09708e4a14f766badee153a42591348a7ce2e84ed88ea2b1 |
| 11006 | A | 077776 | 001 | IRINOTECAN HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | IRINOTECAN HYDROCHLORIDE | FRESENIUS KABI USA | 40MG/2ML (20MG/ML) | AP | ["AP"] | 2008-02-27 | Feb 27, 2008 | No | No | No | RX | FRESENIUS KABI USA LLC | 9f99f629ae7752e621f97cbd573bf1c8b66f5e7a8d4b3c68aa200973835392ac |
| 11007 | A | 078188 | 001 | IRINOTECAN HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | IRINOTECAN HYDROCHLORIDE | FRESENIUS KABI USA | 40MG/2ML (20MG/ML) | | [] | 2008-02-27 | Feb 27, 2008 | No | No | No | DISCN | FRESENIUS KABI USA LLC | 65a45831da4ade0439b5896056b2c9fb57ee14647e7d947569c4231bd9242c45 |
| 11008 | A | 077776 | 002 | IRINOTECAN HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | IRINOTECAN HYDROCHLORIDE | FRESENIUS KABI USA | 100MG/5ML (20MG/ML) | AP | ["AP"] | 2008-02-27 | Feb 27, 2008 | No | No | No | RX | FRESENIUS KABI USA LLC | e49a143182edd1a6e645c6ae56f3bd7550fe39369795df53fdf1600d85fae2a7 |
| 11009 | A | 078188 | 002 | IRINOTECAN HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | IRINOTECAN HYDROCHLORIDE | FRESENIUS KABI USA | 100MG/5ML (20MG/ML) | | [] | 2008-02-27 | Feb 27, 2008 | No | No | No | DISCN | FRESENIUS KABI USA LLC | d382b374ab61e3fedd6da6aeea60ac308fbae08bb963cb1e06e5bdb3d73e9ed5 |
| 11010 | A | 212993 | 001 | IRINOTECAN HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | IRINOTECAN HYDROCHLORIDE | GLAND PHARMA LTD | 40MG/2ML (20MG/ML) | AP | ["AP"] | 2019-11-18 | Nov 18, 2019 | No | No | No | RX | GLAND PHARMA LTD | 92c2a87ea7932f73c3747b9050f5a8da4bb66bd244941dc912662fe6795d9d3e |
| 11011 | A | 212993 | 002 | IRINOTECAN HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | IRINOTECAN HYDROCHLORIDE | GLAND PHARMA LTD | 100MG/5ML (20MG/ML) | AP | ["AP"] | 2019-11-18 | Nov 18, 2019 | No | No | No | RX | GLAND PHARMA LTD | 28378df05cb5d2de7fb0188091a339caab695ca3d6b512af40fffbe4a185dde1 |
| 11012 | A | 091032 | 001 | IRINOTECAN HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | IRINOTECAN HYDROCHLORIDE | HIKMA FARMACEUTICA | 40MG/2ML (20MG/ML) | AP | ["AP"] | 2010-12-20 | Dec 20, 2010 | No | No | No | RX | HIKMA FARMACEUTICA (PORTUGAL) SA | aa2c4e2b6949a846d0c2ccfa86311abacf84a390d8da523a937dc1a895926fd5 |
| 11013 | A | 091032 | 002 | IRINOTECAN HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | IRINOTECAN HYDROCHLORIDE | HIKMA FARMACEUTICA | 100MG/5ML (20MG/ML) | AP | ["AP"] | 2010-12-20 | Dec 20, 2010 | No | No | No | RX | HIKMA FARMACEUTICA (PORTUGAL) SA | d4c5b7d272a4b94a652f6cb6fd07209affb21b51c2392cf0a98ce34df05fec56 |
| 11014 | A | 090016 | 001 | IRINOTECAN HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | IRINOTECAN HYDROCHLORIDE | HISUN PHARM HANGZHOU | 40MG/2ML (20MG/ML) | AP | ["AP"] | 2009-01-28 | Jan 28, 2009 | No | No | No | RX | HISUN PHARMACEUTICAL (HANGZHOU) CO LTD | aba15b46ae5fd8227abb0382831f29a367fff9edd41dfc9ef8d409aba2bc34e4 |
| 11015 | A | 090016 | 002 | IRINOTECAN HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | IRINOTECAN HYDROCHLORIDE | HISUN PHARM HANGZHOU | 100MG/5ML (20MG/ML) | AP | ["AP"] | 2009-01-28 | Jan 28, 2009 | No | No | No | RX | HISUN PHARMACEUTICAL (HANGZHOU) CO LTD | 4f210c214193e5059d8899589357779e32fbd1ab0d0f0fbf062327c8bb0880fc |
| 11016 | A | 077915 | 001 | IRINOTECAN HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | IRINOTECAN HYDROCHLORIDE | HOSPIRA | 40MG/2ML (20MG/ML) | AP | ["AP"] | 2008-02-27 | Feb 27, 2008 | No | No | No | RX | HOSPIRA INC | e9386d048b2b7271473c80bc463325e81d7165d35ccb1ccfe58007d1ad9c8af0 |
| 11017 | A | 077915 | 002 | IRINOTECAN HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | IRINOTECAN HYDROCHLORIDE | HOSPIRA | 100MG/5ML (20MG/ML) | AP | ["AP"] | 2008-02-27 | Feb 27, 2008 | No | No | No | RX | HOSPIRA INC | a9bc02d9a89e1f2746d4e571463aec854043811518a910a38b5e2d8027323e85 |
| 11018 | A | 078796 | 001 | IRINOTECAN HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | IRINOTECAN HYDROCHLORIDE | HOSPIRA | 500MG/25ML (20MG/ML) | AP | ["AP"] | 2008-02-27 | Feb 27, 2008 | No | No | Yes | RX | HOSPIRA INC | f997673c678062456db0def5bb3343b7938bc57a14f6ee218b3a017b8e8abace |
| 11019 | A | 203054 | 001 | IRINOTECAN HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | IRINOTECAN HYDROCHLORIDE | INTAS PHARMS USA | 40MG/2ML (20MG/ML) | AP | ["AP"] | 2017-08-31 | Aug 31, 2017 | No | No | No | RX | INTAS PHARMACEUTICALS USA | 90764412f5fe160ab393335517571b5d7f624be111aa6f03c88c1fe15af7289b |
| 11020 | A | 203054 | 002 | IRINOTECAN HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | IRINOTECAN HYDROCHLORIDE | INTAS PHARMS USA | 100MG/5ML (20MG/ML) | AP | ["AP"] | 2017-08-31 | Aug 31, 2017 | No | No | No | RX | INTAS PHARMACEUTICALS USA | 22176b6c46dcbee7affd3de6bdecf08efdc65216db7d6c3fec3cd28f1dcca647 |
| 11021 | A | 090675 | 002 | IRINOTECAN HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | IRINOTECAN HYDROCHLORIDE | JIANGSU HENGRUI MED | 40MG/2ML (20MG/ML) | AP | ["AP"] | 2011-12-16 | Dec 16, 2011 | No | No | No | RX | JIANGSU HENGRUI MEDICINE CO LTD | de5796a1b11c6b4eb26169c4018aa2b5ba30b65e9a248623b8044fc8a3b39245 |
| 11022 | A | 090675 | 001 | IRINOTECAN HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | IRINOTECAN HYDROCHLORIDE | JIANGSU HENGRUI MED | 100MG/5ML (20MG/ML) | AP | ["AP"] | 2011-12-16 | Dec 16, 2011 | No | No | No | RX | JIANGSU HENGRUI MEDICINE CO LTD | 6cce6108de3548c3386a2437c52685c1be07fca52d72749414f544ee2aa32181 |
| 11023 | A | 078953 | 001 | IRINOTECAN HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | IRINOTECAN HYDROCHLORIDE | NEOPHARMA | 40MG/2ML (20MG/ML) | | [] | 2010-04-15 | Apr 15, 2010 | No | No | No | DISCN | NEOPHARMA INC | e6cf8d05b6ebaa3c4d1ee21fe7a53521ff89469d2f173c805e7ceac0946964a5 |
| 11024 | A | 078953 | 002 | IRINOTECAN HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | IRINOTECAN HYDROCHLORIDE | NEOPHARMA | 100MG/5ML (20MG/ML) | | [] | 2010-04-15 | Apr 15, 2010 | No | No | No | DISCN | NEOPHARMA INC | 1481157f1c29247dc629bca430a2b91bbd974afe5aca69fb864753ce14008003 |
| 11025 | A | 206935 | 001 | IRINOTECAN HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | IRINOTECAN HYDROCHLORIDE | NOVAST LABS | 40MG/2ML (20MG/ML) | AP | ["AP"] | 2017-05-26 | May 26, 2017 | No | No | No | RX | NOVAST LABORATORIES LTD | dba20410a1a320cbaaf6c3cc75197778433db86e3ad92c3cd6943772bc1d6e71 |
| 11026 | A | 206935 | 002 | IRINOTECAN HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | IRINOTECAN HYDROCHLORIDE | NOVAST LABS | 100MG/5ML (20MG/ML) | AP | ["AP"] | 2017-05-26 | May 26, 2017 | No | No | No | RX | NOVAST LABORATORIES LTD | b89b0ef0d3c92a0d76ee19ad122f017acfc2f6ec34df8737806d3190ee5ccf8e |
| 11027 | A | 078122 | 001 | IRINOTECAN HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | IRINOTECAN HYDROCHLORIDE | PLIVA LACHEMA | 40MG/2ML (20MG/ML) | | [] | 2008-10-31 | Oct 31, 2008 | No | No | No | DISCN | PLIVA LACHEMA AS | fc0ca9e350817d206f5039f5b6c5ec8926b4f173413cb3048106d119c6180de2 |
| 11028 | A | 078122 | 002 | IRINOTECAN HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | IRINOTECAN HYDROCHLORIDE | PLIVA LACHEMA | 100MG/5ML (20MG/ML) | | [] | 2008-10-31 | Oct 31, 2008 | No | No | No | DISCN | PLIVA LACHEMA AS | f9ff5ed42897ebaec2dbebf0f5d8cc3e4f4a477be7d113b4ff54350f906a85fd |
| 11029 | A | 203380 | 001 | IRINOTECAN HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | IRINOTECAN HYDROCHLORIDE | QILU | 40MG/2ML (20MG/ML) | AP | ["AP"] | 2016-05-03 | May 3, 2016 | No | No | No | RX | QILU PHARMACEUTICAL CO LTD | ab1089c91aed6f4692a78f4070e7166b821500a4a702829c739e1cb371b2b991 |
| 11030 | A | 203380 | 002 | IRINOTECAN HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | IRINOTECAN HYDROCHLORIDE | QILU | 100MG/5ML (20MG/ML) | AP | ["AP"] | 2016-05-03 | May 3, 2016 | No | No | No | RX | QILU PHARMACEUTICAL CO LTD | 3f494281c2ba8196ebeec3302b39254bfe1560902f249dfe65de2dfe2956717d |
| 11031 | A | 203380 | 003 | IRINOTECAN HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | IRINOTECAN HYDROCHLORIDE | QILU | 300MG/15ML (20MG/ML) | AP | ["AP"] | 2016-05-03 | May 3, 2016 | No | No | No | RX | QILU PHARMACEUTICAL CO LTD | 00dc17df5b66ef6e67757ee98f42f7ebaf3208fbb3a410ffc7575406c8d436dd |
| 11032 | A | 077994 | 001 | IRINOTECAN HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | IRINOTECAN HYDROCHLORIDE | SANDOZ | 40MG/2ML (20MG/ML) | | [] | 2008-02-27 | Feb 27, 2008 | No | No | No | DISCN | SANDOZ INC | 8fcda50c796b3905d58d07f3f9be68bcb170d52f18f4d93cb914f67aef88d8e8 |
| 11033 | A | 077994 | 002 | IRINOTECAN HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | IRINOTECAN HYDROCHLORIDE | SANDOZ | 100MG/5ML (20MG/ML) | | [] | 2008-02-27 | Feb 27, 2008 | No | No | No | DISCN | SANDOZ INC | 005c03c870414f46ecf273a35a33799f03adf2511b2352999591a41fbe6714e7 |
| 11034 | A | 090137 | 001 | IRINOTECAN HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | IRINOTECAN HYDROCHLORIDE | SANDOZ INC | 40MG/2ML (20MG/ML) | | [] | 2009-11-12 | Nov 12, 2009 | No | No | No | DISCN | SANDOZ INC | 1d9a2d928ab3404d13366d12467d13661902bebf8d04cac73ad10cb8786a2f89 |
| 11035 | A | 090137 | 002 | IRINOTECAN HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | IRINOTECAN HYDROCHLORIDE | SANDOZ INC | 100MG/5ML (20MG/ML) | | [] | 2009-11-12 | Nov 12, 2009 | No | No | No | DISCN | SANDOZ INC | 07e5f8e0855813a9974493f94af6a7147e5412d3f92e98bd8ba7c3b55417c2e9 |
| 11036 | A | 208718 | 001 | IRINOTECAN HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | IRINOTECAN HYDROCHLORIDE | SHILPA | 40MG/2ML (20MG/ML) | AP | ["AP"] | 2018-12-28 | Dec 28, 2018 | No | No | No | RX | SHILPA MEDICARE LTD | cad38904b76781e0bd328071965ea49741a536744e01613311caa2be7af320e0 |
| 11037 | A | 208718 | 002 | IRINOTECAN HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | IRINOTECAN HYDROCHLORIDE | SHILPA | 100MG/5ML (20MG/ML) | AP | ["AP"] | 2018-12-28 | Dec 28, 2018 | No | No | No | RX | SHILPA MEDICARE LTD | fe6593d4e77e86a10c21912c8dd1ad346c11487aa67c8ab74edc60248c225fd6 |
| 11038 | A | 208718 | 003 | IRINOTECAN HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | IRINOTECAN HYDROCHLORIDE | SHILPA | 300MG/15ML (20MG/ML) | AP | ["AP"] | 2019-08-16 | Aug 16, 2019 | No | No | No | RX | SHILPA MEDICARE LTD | f93c2b274c89176117dfe70a98f666b30e6c47dba2009100c905bdd6ecb9878b |
| 11039 | A | 078805 | 001 | IRINOTECAN HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | IRINOTECAN HYDROCHLORIDE | SUN PHARMA GLOBAL | 40MG/2ML (20MG/ML) | | [] | 2008-04-21 | Apr 21, 2008 | No | No | No | DISCN | SUN PHARMA GLOBAL INC | df696fdb943a2571fe30119815687198ec107beff62e837e2e23ccba3a13a04a |
| 11040 | A | 078805 | 002 | IRINOTECAN HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | IRINOTECAN HYDROCHLORIDE | SUN PHARMA GLOBAL | 100MG/5ML (20MG/ML) | | [] | 2008-04-21 | Apr 21, 2008 | No | No | No | DISCN | SUN PHARMA GLOBAL INC | c047be68d546ea7c007b22ab3e493d66e607aa55e7cb4ae6d3e530ef4e1f9899 |
| 11041 | A | 090101 | 002 | IRINOTECAN HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | IRINOTECAN HYDROCHLORIDE | TEVA PHARMS USA | 40MG/2ML (20MG/ML) | AP | ["AP"] | 2008-02-27 | Feb 27, 2008 | No | No | No | RX | TEVA PHARMACEUTICALS USA | 081f15ea0ee4ba49a61f0a9c758cb490d3a155365b5defcedfeefd8d4f0c7f16 |
| 11042 | A | 090101 | 003 | IRINOTECAN HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | IRINOTECAN HYDROCHLORIDE | TEVA PHARMS USA | 100MG/5ML (20MG/ML) | AP | ["AP"] | 2008-02-27 | Feb 27, 2008 | No | No | No | RX | TEVA PHARMACEUTICALS USA | 680e1753a40e18811b7816c341f94b1904f0895c7743535bc1a2eb636dcac2ac |
| 11043 | A | 090101 | 001 | IRINOTECAN HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | IRINOTECAN HYDROCHLORIDE | TEVA PHARMS USA | 500MG/25ML (20MG/ML) | AP | ["AP"] | 2008-11-26 | Nov 26, 2008 | No | No | No | RX | TEVA PHARMACEUTICALS USA | 7e5b578463a6b73b00ea29cf6b176ed74786b407bf68fd392ee853594960981f |
| 11044 | A | 078753 | 001 | IRINOTECAN HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | IRINOTECAN HYDROCHLORIDE | WEST-WARD PHARMS INT | 40MG/2ML (20MG/ML) | AP | ["AP"] | 2008-12-24 | Dec 24, 2008 | No | No | No | RX | WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD | 0a7143055d5fd5719bc92aceb98cd23a51598e5088923b553b1ea757033866af |
| 11045 | A | 078753 | 002 | IRINOTECAN HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | IRINOTECAN HYDROCHLORIDE | WEST-WARD PHARMS INT | 100MG/5ML (20MG/ML) | AP | ["AP"] | 2008-12-24 | Dec 24, 2008 | No | No | No | RX | WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD | 77dba703d646a31d97c149df347e63d1c4d7d94195f2028c1d850649e77fe450 |
| 11046 | A | 090393 | 002 | IRINOTECAN HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | IRINOTECAN HYDROCHLORIDE | ZENNOVA | 40MG/2ML (20MG/ML) | AP | ["AP"] | 2011-05-13 | May 13, 2011 | No | No | No | RX | ZENNOVA PHARMACEUTICALS CHENGDU CO LTD | 0957451abf3057124d12733fc4236ca3547648f2d1fde064b8a0e08863308ca0 |
| 11047 | A | 090393 | 003 | IRINOTECAN HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | IRINOTECAN HYDROCHLORIDE | ZENNOVA | 100MG/5ML (20MG/ML) | AP | ["AP"] | 2011-05-13 | May 13, 2011 | No | No | No | RX | ZENNOVA PHARMACEUTICALS CHENGDU CO LTD | fa1fafe564de29594324d81f2335ba90b10b37acec162668287d878e85cd8eac |
| 11048 | N | 010787 | 002 | IRON DEXTRAN | INJECTABLE;INJECTION | INJECTABLE | INJECTION | IRON DEXTRAN | SANOFI AVENTIS US | EQ 50MG IRON/ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | SANOFI AVENTIS US LLC | febc61ece365c2806a554ee9fc4d7d0a9b7d0d946e06012b2e17a7c70981417a |
| 11049 | A | 080925 | 001 | MEPIVACAINE HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | ISOCAINE HYDROCHLORIDE | SEPTODONT INC | 3% | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | SEPTODONT INC | 883a180e6730c62fef9c0477a13b4fe2f2cb7b668953b298ae319e604de551e7 |
| 11050 | A | 084697 | 001 | LEVONORDEFRIN; MEPIVACAINE HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | ISOCAINE HYDROCHLORIDE W/ LEVONORDEFRIN | SEPTODONT INC | 0.05MG/ML;2% | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | SEPTODONT INC | ca7f79937f0201164a99f73341266f196fe501277a2b2ea1462e066ebdf3cb04 |
| 11051 | N | 019867 | 001 | CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM CITRATE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | ISOLYTE E IN DEXTROSE 5% IN PLASTIC CONTAINER | B BRAUN | 35MG/100ML;5GM/100ML;30MG/100ML;74MG/100ML;640MG/100ML;500MG/100ML;74MG/100ML | | [] | 1993-12-20 | Dec 20, 1993 | No | No | No | DISCN | B BRAUN MEDICAL INC | 75463a41efe1f1b46d4638ec2ea1123828513a62d6d4c660441b3b02d8ac77f4 |